Effects of galactosylation in immunoglobulin g from all-atom molecular dynamics simulations

Journal of Physical Chemistry B

Volumn 118, Issue 33, 2014, Pages 9844-9851

  Fortunato, Michael E ^a   Colina, Coray M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR DYNAMICS; MONOCLONAL ANTIBODIES; PROTEINS; SURFACE PLASMON RESONANCE;

AGGREGATION RESISTANCE; ATOMISTIC MOLECULAR DYNAMICS SIMULATIONS; DEGREE OF FLEXIBILITY; GALACTOSE RESIDUES; MOLECULAR DYNAMICS SIMULATIONS; PROTEIN-CARBOHYDRATE INTERACTIONS; ROTATIONAL ORIENTATION; THERAPEUTIC TREATMENTS;

CARBOHYDRATES;

CARBOHYDRATE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

CHEMISTRY; GLYCOSYLATION; METABOLISM; MOLECULAR DYNAMICS;

ANTIBODIES, MONOCLONAL; CARBOHYDRATES; GLYCOSYLATION; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MOLECULAR DYNAMICS SIMULATION;

EID: 84906497063     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp504243e     Document Type: Article

References (32)

1. Bonilla, F.; Geha, R. In Blood: Principles and Practice of Hematology, 2 nd ed.; Handin, R. I., Lux, S. E., Stossel, T. P., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2003; Chapter 22: Primary Immunodeficiency Diseases and Immunoproteins.
2. Porter, R. Separation and Isolation of Fractions of Rabbit Gamma-Globulin Containing the Antibody and Antigenic Combining Sties Nature 1958, 182, 670-671
3. Harris, L. J.; Larson, S. B.; Hasel, K. W.; McPherson, A. Refined Structure of an Intact IgG2a Monoclonal Antibody Biochemistry 1997, 36, 1581-1597
4. Harris, L. J.; Skaletsky, E.; McPherson, A. Crystallographic Structure of an Intact IgG1Monoclonal Antibody J. Mol. Biol. 1998, 275, 861-872
5. Saphire, E.; Parren, P.; Pantophlet, R.; Zwick, M.; Morris, G.; Rudd, P.; Dwek, R.; Stanfield, R.; Burton, D.; Wilson, I. Crystal Structure of a Neutralizing Human IGG Against HIV-1: a Template for Vaccine Design Science 2001, 293, 1155-1159
6. Dalziel, M.; Crispin, M.; Scanlan, C.; Zitzmann, N.; Dwek, R. Emerging Principles for the Therapeutic Exploitation of Glycosylation Science 2014, 343, 37-45
7. Chennamsetty, N.; Helk, B.; Voynov, V.; Kayser, V.; Trout, B. L. Aggregation-Prone Motifs in Human Immunoglobulin G J. Mol. Biol. 2009, 391, 404-413
8. Voynov, V.; Chennamsetty, N.; Kayser, V.; Helk, B.; Forrer, K.; Zhang, H.; Fritsch, C.; Heine, H.; Trout, B. Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation PLoS One 2009, 4, e8425
9. Wang, X.; Kumar, S.; Buck, P.; Singh, S. Impact of Deglycosylation and Thermal Stress on Conformational Stability of a Full Length Murine IgG2a Monoclonal Antibody: Observations from Molecular Dynamics Simulations Proteins 2013, 81, 443-460
10. Kortkhonjia, E.; Brandman, R.; Zhou, J.; Voelz, V.; Chorny, I.; Kabakoff, B.; Patapoff, T.; Dill, K.; Swartz, T. Probing Antibody Internal Dynamics with Fluorescence Anisotropy and Molecular Dynamics Simulations mAbs 2013, 5, 306-322
11. Pucic, M. High Throughput Isolation and Glycosylation Analysis of IgG-Variability and Heritability of the IgG Glycome in Three Isolated Human Populations Mol. Cell. Proteomics 2011, 10, M111.010090
12. Wormald, M.; Rudd, P.; Harvey, D.; Chang, S.; Scragg, I.; Dwek, R. Variations in Oligosaccharide-protein Interactions in Immunoglobulin G Determine the Site-specific Glycosylation Profiles and Modulate the Dynamic Motion of the Fc Oligosaccharides Biochemistry 1997, 36, 1370-1380
13. Iida, S.; Misaka, H.; Inoue, M.; Shibata, M.; Nakano, R.; Yamane-Ohnuki, N.; Wakitani, M.; Yano, K.; Shitara, K.; Satoh, M. Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to Fc?RIIIa Clin. Cancer Res. 2006, 12, 2879-2887
14. Kanda, Y.; Yamada, T.; Mori, K.; Okazaki, A.; Inoue, M.; Kitajima-Miyama, K.; Kuni-Kamochi, R.; Nakano, R.; Yano, K.; Kakita, S.; Shitara, K.; Satoh, M. Comparison of Biological Activity among Nonfucosylated Therapeutic IgG1 Antibodies with Three Different N-linked Fc Oligosaccharides: the High-Mannose, Hybrid, and Complex Types Glycobiology 2006, 17, 104-118
15. Parekh, R. B.; Dwek, R. A.; Sutton, B. J.; Fernandes, D. L.; Leung, A.; Stanworth, D.; Rademacher, T. Association of Rheumatoid Arthritis and Primary Osteoarthritis with Changes in the Glycosylation Pattern of Total Serum IgG Nature 1985, 316, 452-457
16. Malhotra, R.; Wormald, M.; Rudd, P.; Fischer, P.; Dwek, R.; Sim, R. Glycosylation Changes of IgG Associated With Rheumatoid Arthritis Can Activate Complement via the Mannose-binding Protein Nat. Med. 1995, 1, 237-243
17. Anthony, R.; Nimmerjahn, F.; Ashline, D.; Reinhold, V.; Paulson, J.; Ravetch, J. Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc Science 2008, 320, 373-376
18. Collin, M.; Ehlers, M. The Carbohydrate Switch Between Pathogenic and Immunosuppressive Antigen-specific Antibodies Exp. Dermatol. 2013, 22, 511-514
19. DeLano, W.; Ultsch, M.; de Vos, A.; Wells, J. Convergent Solutions to Binding at a Protein-Protein Interface Science 2000, 287, 1279-1283
20. Idusogie, E.; Presta, L.; Gazzano-Santoro, H.; Totpal, K.; Wong, P.; Ultsch, M.; Meng, Y.; Mulkerrin, M. Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc J. Immunol. 2000, 164, 4178-4184
21. Barb, A.; Prestegard, J. NMR Analysis Demonstrates Immunoglobulin G N-glycans are Accessible and Dynamic Nat. Chem. Biol. 2011, 7, 147-153
22. Case, D. AMBER 12; University of California: San Francisco, 2012.
23. Hornak, V.; Abel, R.; Okur, A.; Strockbrine, B.; Roitberg, A.; Simmerling, C. Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters Proteins 2006, 65, 712-725
24. Kirschner, K.; Yongye, A.; Tschampel, S.; Daniels, C.; Foley, B.; Woods, R. GLYCAM06 J. Comput. Chem. 2008, 29, 622-655
25. Salomon-Ferrer, R.; Goetz, A.; Poole, D.; Le Grand, S.; Walker, R. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald J. Chem. Theory Comput. 2013, 9, 3878-3888
26. Brandt, J. P.; Patapoff, T. W.; Aragon, S. R. Construction, MD simulation, and Hydrodynamic Validation of an All-Atom Model of a Monoclonal IgG Antibody Biophys. J. 2010, 99, 905-913
27. Clark, N.; Zhang, H.; Krueger, S.; Lee, H.; Ketchem, R.; Kerwin, B.; Kanapuram, S.; Treuheit, M.; McAuley, A.; Curtis, J. Small-Angle Neutron Scattering Study of a Monoclonal Antibody Using Free-Energy Constraints J. Phys. Chem. B 2013, 117, 14029-14038
28. Rayner, L.; Kadkhodayi-Kholghi, N.; Heenan, R.; Gor, J.; Dalby, P.; Perkins, S. The Solution Structure of Rabbit IgG Accounts for Its Interactions with the Fc Receptor and Complement C1q and Its Conformational Stability J. Mol. Biol. 2013, 425, 506-523
29. Pilz, I.; Schwarz, E.; Durchschein, W.; Licht, A.; Sela, M. Effect of Cleaving Interchain Disulfide Bridges on the Radius of Gyration and Maximum Length of Anti-poly(D-alanyl) Antibodies Before and After Reaction with Tetraalanine Hapten Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 117-121
30. Borrok, M. J.; Jung, S. T.; Kang, T. H.; Monzingo, A. F.; Georgiou, G. Revisiting the Role of Glycosylation in the Structure of Human IgG Fc ACS Chem. Biol. 2012, 7, 1596-1602
31. Jo, S.; Lee, H. S.; Skolnick, J.; Im, W. Restricted N-glycan Conformational Space in the PDB and Its Implication in Glycan Structure Modeling PLoS Comput. Biol. 2013, 9, e1002946
32. Chaudhri, A.; Zarraga, I. E.; Kamerzell, T. J.; Brandt, J. P.; Patapoff, T. W.; Shire, S. J.; Voth, G. A. Coarse-Grained Modeling of the Self-Association of Therapeutic Monoclonal Antibodies J. Phys. Chem. B 2012, 116, 8045-8057